InvestorsHub Logo
Followers 80
Posts 24708
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 05/13/2019 7:50:26 AM

Monday, May 13, 2019 7:50:26 AM

Post# of 27626
SESN - 1.16 Pre-market now at 1.22/1.24

Sesen Bio Reports First Quarter 2019 Financial Results and Updated, Preliminary Primary and Additional Secondary Endpoint Data from Phase 3 VISTA Trial for High-Risk Non-Muscle Invasive Bladder Cancer

https://www.tradescores.com/StockReport/sesn
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.